Online citations, reference lists, and bibliographies.

Who Is Using Chronic Acid-suppression Therapy And Why?

B. Jacobson, T. Ferris, Tara L. Shea, P. Greenberg, T. Wang
Published 2000 · Medicine
Cite This
Download PDF
Analyze on Scholarcy

This paper is referenced by
Impact of Acid Suppression on Upper Gastrointestinal pH and Motility
Whitney Michalek (2010)
We have had a gutful: The need for deprescribing proton pump inhibitors
M. Naunton (2018)
Clostridium difficile infection in rural Ontario: a retrospective multisite population-based study.
Ken Babey (2015)
The inaccuracy of ICD-9-CM Code 530.2 for identifying patients with Barrett's esophagus.
Brian Jacobson (2008)
Prescription des inhibiteurs de la pompe à protons chez les sujets âgés : adéquation aux recommandations
Claire Schönheit (2013)
Effects of Omeprazole on the Pharmacokinetic Profiles of Lisdexamfetamine Dimesylate and Extended-Release Mixed Amphetamine Salts in Adults
Mary B. Haffey (2009)
Gastrointestinal Behavior of Weakly Acidic BCS Class II Drugs in Man--Case Study of Diclofenac Potassium.
Jens Van Den Abeele (2016)
The Effect of Pantoprazole on Bone Turnover in Ovariectomized ICR Mice
Eun-Hye Lim (2011)
On-Demand Therapy Is a Valid Strategy in GERD Patients: Pros and Cons
Andreas Leodolter (2007)
Mandibular Implant Prostheses
E. Emami (2018)
Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?
J. Heidelbaugh (2012)
Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage?
Mario Visconti (2015)
Clinical trial: long-term use of proton pump inhibitors in primary care patients - a cross sectional analysis of 901 patients.
Christina Reimer (2009)
Uso de omeprazol em hospital universitário de Porto Alegre-RS (Brasil)
Leonardo Munari (2004)
Are proton pump inhibitors associated with an increased risk of Clostridium difficile infection after considering confounding variables?
K Hughes (2017)
Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.
Gati A. Goel (2012)
Inadequate Use of Acid-Suppressive Therapy in Hospitalized Patients and Its Implications for General Practice
R. Scagliarini (2005)
American gastroenterological association technical review on the evaluation of dyspepsia.
N. Talley (2005)
Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study
Anton Pottegård (2016)
Acid-Suppressive Therapy and Risk of Infections: Pros and Cons
L. Fisher (2017)
Practice patterns for managing Helicobacter pylori infection and upper gastrointestinal symptoms.
Colin W. Howden (2007)
Effects of duration of proton pump inhibitor (PPI) therapy on markers of bone health in men and post-menopausal women
Zarina Pabin (2010)
Hip Fracture Long-term Proton Pump Inhibitor Therapy and Risk of Correction
Y. Yang (2006)
Use of Acid-Suppressive Drugs and Risk of Fracture: A Meta-analysis of Observational Studies
Chun-Sick Eom (2011)
Effects of rabeprazole on bone metabolic disorders in a gastrectomized rat model.
Yuki Yamasaki (2016)
A Program to Improve the Management of Patients on Long-Term Acid Suppression Medication
Tara L. Shea (2002)
The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.
V. Savarino (2017)
Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis
Allison A. Lambert (2015)
Clinical Considerations for Proton Pump Inhibitor (PPI) Use
Gregory W. H. Smith (2010)
Déprescrire les inhibiteurs de la pompe à protons: Lignes directrices de pratique clinique fondées sur les données probantes.
B. Farrell (2017)
Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.
J. Zacny (2005)
Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.
John A. Hermos (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar